KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exact Sciences (EXAS) Operating Expenses (2016 - 2025)

Exact Sciences has reported Operating Expenses over the past 16 years, most recently at $698.4 million for Q4 2025.

  • Quarterly Operating Expenses fell 49.08% to $698.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, down 17.05% year-over-year, with the annual reading at $2.5 billion for FY2025, 17.05% down from the prior year.
  • Operating Expenses was $698.4 million for Q4 2025 at Exact Sciences, up from $609.5 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $1.4 billion in Q4 2024 and troughed at -$16.4 million in Q4 2023.
  • The 5-year median for Operating Expenses is $613.9 million (2021), against an average of $599.3 million.
  • Year-over-year, Operating Expenses tumbled 256.31% in 2023 and then skyrocketed 8443.55% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $555.0 million in 2021, then crashed by 98.11% to $10.5 million in 2022, then tumbled by 256.31% to -$16.4 million in 2023, then skyrocketed by 8443.55% to $1.4 billion in 2024, then tumbled by 49.08% to $698.4 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Operating Expenses are $698.4 million (Q4 2025), $609.5 million (Q3 2025), and $564.6 million (Q2 2025).